Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View


SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of


GlobeNewswire Inc | Oct 26, 2020 01:37PM EDT

October 26, 2020

WILMINGTON, Del., Oct. 26, 2020 (GLOBE NEWSWIRE) --

Rigrodsky & Long, P.A. announces that it is investigating:

Concho Resources Inc. (NYSE: CXO) regarding possible breaches of fiduciary duties and other violations of law related to Concho Resources agreement to be acquired by ConocoPhillips. Under the terms of the agreement Concho Resources shareholders will receive 1.46 shares of ConocoPhillips common stock per share. To learn more about this investigation and your rights, visit: https://www.rigrodskylong.com/cases-concho-resources-inc.

BioSpecifics Technologies Corp. (NASDAQ GM: BSTC) regarding possible breaches of fiduciary duties and other violations of law related to BioSpecifics Technologies agreement to be acquired by Endo International plc. Under the terms of the agreement, BioSpecifics Technologies shareholders will receive $88.50 in cash per share. To learn more about this investigation and your rights, visit: https://www.rigrodskylong.com/cases-biospecifics-technologies-corp.

CIT Group Inc. (NYSE: CIT) regarding possible breaches of fiduciary duties and other violations of law related to CIT Groups agreement to be acquired by First Citizens BancShares, Inc. Under the terms of the agreement, CIT Groups shareholders will receive 0.0620 of a share of First Citizens Bancshares common stock per share. To learn more about this investigation and your rights, visit: https://www.rigrodskylong.com/cases-cit-group-inc.

Eidos Therapeutics, Inc. (NASDAQ GS: EIDX) regarding possible breaches of fiduciary duties and other violations of law related to Eidos agreement to be acquired by BridgeBio Pharma, Inc. Under the terms of the agreement, Eidos shareholders will receive 1.85 shares of BridgeBio common stock or $73.26 in cash per share. To learn more about this investigation and your rights, visit: https://www.rl-legal.com/cases-eidos-therapeutics-inc.

You may also contact Seth D. Rigrodsky or Gina M. Serra cost and obligation free at (888) 969-4242 or info@rl-legal.com.

Rigrodsky & Long, P.A., with offices in Delaware and New York, has recovered hundreds of millions of dollars on behalf of investors and achieved substantial corporate governance reforms in securities fraud and corporate class actions nationwide.

Attorney advertising. Prior results do not guarantee a similar outcome.

CONTACT:

Rigrodsky & Long, P.A.Seth D. RigrodskyGina M. Serra(888) 969-4242 (Toll Free)(302) 295-5310Fax: (302) 654-7530info@rl-legal.com https://rl-legal.com







Share
About
Pricing
Policies
Markets
API
Info
tz UTC-5
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC